Pharma Stocks
-
Jim Cramer Says Biotech is The Hottest Group in The Market Right Now
Quick Read Cramer calls IBB the hottest group in the market, up 51% over the past year, with LLY completing…
Read More » -
Is UroGen Pharma (URGN) Undervalued Following FDA Clearance For UGN 501?
Why the UroGen Pharma Stock Move Is Tied to UGN-501 UroGen Pharma (URGN) is in focus after the U.S. Food…
Read More » -
Buy Senores Pharma; target of Rs 1640: Choice Institutional Equities
Choice Institutional Equities’s report on Senores Pharma SENORES is strengthening its position as a US-focused player through a differentiated product…
Read More » -
Is Crinetics Pharmaceuticals, Inc. (CRNX) Stock a Buying Opportunity After a 44% Pullback?
When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off…
Read More » -
Royalty Pharma (RPRX) Could Be 2% Undervalued On Russell 1000 Defensive Index Addition
Royalty Pharma (RPRX) has just been added to both the Russell 1000 Value-Defensive Index and the Russell 1000 Defensive Index,…
Read More » -
Did EMA’s Positive Hopledo Ruling Just Shift Amneal Pharmaceuticals’ (AMRX) Investment Narrative?
Zambon and Amneal Pharmaceuticals recently announced that the EMA’s Committee for Medicinal Products for Human Use issued a positive opinion…
Read More » -
ARS Pharmaceuticals Announces CEO Succession
ARS Pharmaceuticals, Inc. Richard Lowenthal, Chief Executive Officer, Transitioning following More than a Decade of Leadership Since Co-Founding the Company Donn…
Read More » -
IGC Pharma CEO and Principal Financial Officer Purchase More Than $1.15 Million of Common Stock Directly from the Company
Senior management elects restricted common stock at $0.27 per share in lieu of repayment of amounts owed, including more than…
Read More » -
Is Amylyx Pharmaceuticals (AMLX) A Bargain Following Russell Index Removals?
Amylyx Pharmaceuticals (AMLX) has just been removed from several Russell equity indexes, a technical event that can prompt index tracking…
Read More » -
Why Island Pharmaceuticals (ASX:ILA) Shares Are Trading Higher On Tuesday?
Highlights • Island Pharmaceuticals shares rose 26.67% on 7 July 2026 after announcing government and regulatory approvals for Galidesivir use…
Read More »